Get the Stockscreener App
25.47
0.32%
0.0801
Xoma Corporation stock is traded at $25.47, with a volume of 4,375.
It is up +0.32% in the last 24 hours and up +0.51% over the past month.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
See More
Previous Close:
$25.39
Open:
$25.46
24h Volume:
4,375
Relative Volume:
2.47
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.17%
1M Performance:
+0.51%
6M Performance:
-1.13%
1Y Performance:
-0.90%
1-Day Range:
$25.45
$25.47
1-Week Range:
$25.38
$25.47
52-Week Range:
$24.70
$25.87
Xoma Corporation Stock (XOMAO) Company Profile
Name
Xoma Corporation
Sector
Industry
Phone
510 204 7200
Address
2200 Powell Street, Suite 310, EmeryVille
Compare XOMAO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMAO
Xoma Corporation
|
25.47 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Xoma Corporation Stock (XOMAO) Latest News
Charles Schwab Investment Management Inc. Grows Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA stock touches 52-week low at $19.9 amid market shifts - Investing.com India
HC Wainwright Reiterates Buy Rating for XOMA (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMAO) Sees Significant Growth in Short Interest - The AM Reporter
H.C. Wainwright maintains Buy rating on XOMA with $104 target By Investing.com - Investing.com South Africa
The Analyst Verdict: XOMA Royalty In The Eyes Of 4 Experts - Benzinga
H.C. Wainwright maintains Buy rating on XOMA with $104 target - Investing.com
XOMA Co. (NASDAQ:XOMAO) Short Interest Up 110.7% in March - Defense World
Xoma royalty’s chief investment officer Bradley Sitko buys $98,751 in shares By Investing.com - Investing.com Australia
Long Term Trading Analysis for (XOMA) - news.stocktradersdaily.com
XOMA (NASDAQ:XOMA) Raised to Hold at StockNews.com - Defense World
HC Wainwright Estimates XOMA’s Q1 Earnings (NASDAQ:XOMA) - Defense World
HC Wainwright Reiterates “Buy” Rating for XOMA (NASDAQ:XOMA) - Defense World
HC Wainwright Reaffirms “Buy” Rating for XOMA (NASDAQ:XOMA) - The AM Reporter
Equities Analysts Set Expectations for XOMA FY2025 Earnings - Defense World
XOMA Royalty Declares Quarterly Preferred Stock Dividends - The Manila Times
XOMA Royalty Declares Quarterly Preferred Stock Dividends - Benzinga
Leerink Partnrs Estimates XOMA’s Q1 Earnings (NASDAQ:XOMA) - Defense World
XOMA Royalty Reports Strong 2024 Financial Growth - TipRanks
XOMA stock holds $104 target despite earnings miss - Investing.com
XOMA Royalty Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
XOMA Royalty Corp (XOMA) Reports Q4 EPS of -$0.30, Revenue of $8 - GuruFocus.com
XOMA Royalty Corp reports results for the quarter ended December 31Earnings Summary - TradingView
XOMA Royalty Corp SEC 10-K Report - TradingView
XOMA Royalty Corporation Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements - The Manila Times
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights ... - Bluefield Daily Telegraph
When (XOMAP) Moves Investors should Listen - news.stocktradersdaily.com
Risks Still Elevated At These Prices As XOMA Royalty Corporation (NASDAQ:XOMA) Shares Dive 25% - Simply Wall St
(XOMA) Investment Report - Stock Traders Daily
Rhumbline Advisers Raises Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Purchased by New York State Common Retirement Fund - Defense World
XOMA (XOMA) to Release Earnings on Friday - Defense World
(XOMAP) Long Term Investment Analysis - Stock Traders Daily
XOMA Royalty Corp expected to post a loss of 30 cents a shareEarnings Preview - TradingView
How the (XOMAP) price action is used to our Advantage - Stock Traders Daily
Short Interest in XOMA Co. (NASDAQ:XOMAP) Expands By 58.5% - The AM Reporter
XOMA stock touches 52-week low at $21.07 amid market shifts - Investing.com India
XOMA stock touches 52-week low at $21.07 amid market shifts By Investing.com - Investing.com South Africa
Trend Tracker for (XOMAO) - Stock Traders Daily
(XOMA) Investment Analysis - Stock Traders Daily
Idera Pharmaceuticals and XOMA Find Paths to Financial Growth - ACCESS Newswire
XOMA Royalty Corporation's (NASDAQ:XOMA) largest shareholders are retail investors with 38% ownership, institutions own 36% - Yahoo Finance
XOMA (NASDAQ:XOMA) Cut to "Sell" at StockNews.com - MarketBeat
XOMA (NASDAQ:XOMA) Downgraded by StockNews.com to Sell - Defense World
StockNews.com Downgrades XOMA (NASDAQ:XOMA) to Sell - Armenian Reporter
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences - Yahoo Finance
XOMA Royalty to Present at Investor Conferences in March - GlobeNewswire
Can XOMA's March Investor Conferences Reveal New Growth Strategy? - StockTitan
How to Take Advantage of moves in (XOMAP) - Stock Traders Daily
Acuitas Investments LLC Reduces Stock Holdings in XOMA Co. (NASDAQ:XOMA) - MarketBeat
Xoma Corporation Stock (XOMAO) Financials Data
There is no financial data for Xoma Corporation (XOMAO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.89%
0.13%
Cap:
|
Volume (24h):